The Lakers announced on Saturday night that their blockbuster trade with the Charlotte Hornets to acquire Williams has been rescinded. It has been rescinded due to Charlotte's inability to meet a ...

Some NFL mock drafts hit much harder than others, and in the latest 2025 first-round mock draft from Pro Football Focus, lead draft analyst Trevor Sikkema hits Chicago Bears fans with a haymaker ...

The leadup to 2025 NBA trade deadline was one of the more hectic trade season's in recent memory, with a number of high-profile pieces switching teams. The Oklahoma City Thunder made a few trades ...

NHL hockey insider Elliotte Friedman revealed that teams are potentially gearing up for some big trades during the 4 Nations Face-Off. Speaking ahead of the tournament, Friedman touched on how ...

He had not played since Christmas due to an injury and then was the main part of a blockbuster trade from the Dallas Mavericks to the Lakers. As fans received Doncic T-shirts, and he stepped onto ...

Those who have been paying attention to Thunderbolts* will recall that Bob was prominently featured as a character in the first trailer for the blockbuster that arrived in September, but that ...

The Denver Broncos finished the regular season with a 38-0 whooping of the Skeleton Kansas City Chiefs. Their all-too-brief postseason appearance ended very differently, as the Buffalo Bills ...

China’s Contemporary Amperex Technology (CATL), the world’s largest producer of batteries for electric vehicles and a supplier for Tesla, has applied for a listing in Hong Kong, setting sights ...

An action-packed blockbuster that swept up nearly half a billion at the box office will be coming to the small screen in the UK for the first time this weekend. Tom Holland and Mark Wahlberg ...

The shock of the Dallas Mavericks trading Luka Dončić to the Los Angeles Lakers hasn’t faded, but now, the reasons behind the move are becoming clearer. New Mavericks owner Patrick Dumont is ...

Drugs for metabolic diseases, vaccines, and cancer therapies feature among new product launches this year that could top $1 billion in annual sales or be clinical "game changers" in the next five ...

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...